| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $9.3M | -0.5% |
| SG&A Expense | $6.0M | +27.5% |
| Operating Income | -$15.3M | -8.8% |
| Interest Expense | $7K | -24.3% |
| Income Tax | $0 | — |
| Net Income | -$15.3M | -8.8% |
| EPS (Basic) | -$11.22 | +32.0% |
| EPS (Diluted) | -$11.22 | +32.0% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $10.1M | +100.9% |
| Current Assets | $12.6M | +68.0% |
| Total Assets | $13.1M | +49.1% |
| Current Liabilities | $4.9M | +130.4% |
| Total Liabilities | $4.9M | +130.4% |
| Stockholders' Equity | $8.1M | +22.8% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$10.6M | +22.0% |
| Capital Expenditures | $4K | -23.1% |
| Investing Cash Flow | -$4K | +23.1% |
| Financing Cash Flow | $15.6M | +246.3% |
| Free Cash Flow | -$10.6M | +22.0% |